Please ensure Javascript is enabled for purposes of website accessibility

Nano-X Imaging Receives FDA Clearance for X-Ray Device

By Taylor Carmichael - Updated Apr 5, 2021 at 11:46AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company will start shipping its X-ray machines to hospitals in the fourth quarter of 2021.

Nano-X Imaging (NNOX 1.37%) announced on Friday that its X-ray device received clearance from the Food and Drug Administration. The Israeli company, which just went public on the Nasdaq last year, expects to file for two more clearances from the FDA later this year.

"Obtaining 501(K) clearance from the FDA for our single-source Nanox.ARC digital X-ray is a significant step forward along our U.S. regulatory pathway," CEO Ran Poliakine said in a press release. "We remain on track to commence shipments in the fourth quarter of 2021 and the first quarter of 2022 with the goal of finalizing deployment of the initial 15,000 Nanox.ARC systems by the end of 2024."  

Nano-X device consisting of a 6-foot metal cot and a large semi-circle X-ray device that moves back and forth around the cot.

Image source: Nano-X Imaging.

Nano-X has follow-up applications to the FDA for a multisource version of its X-ray device, as well as the cloud software that will allow medical screening as a service. The multisource Nanox device will combine data from several X-rays, similar to a computerized axial tomography (CAT) scan. That's the device the company will market to hospitals.

The company's breakthrough was to replace the heating element in traditional X-rays with a digital machine that relies upon nanotechnology. This tech allows Nano-X to dramatically reduce the manufacturing cost of these large CAT scanners, from over $1 million to about $10,000. And the price of an X-ray will drop from about $300 to $40. The company will take a slice of revenue every time one of its X-ray devices is used.

Back in the fall, many shorts said the company was a fraud and the device would never work. Nano-X is up 24% in early trading on Monday.


Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Nano-X Imaging Ltd. Stock Quote
Nano-X Imaging Ltd.
$9.65 (1.37%) $0.13

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.